Stem Cell Market: Opportunities and Challenges
Stem cell biology is a promising and emerging field of the life sciences. Advances in biological sciences and the development of human stem cells are bringing new hope for the treatment of many diseases such as Parkinson’s disease, diabetes, heart diseases and cancer as well as injuries for which there has previously been no effective treatment. The medical stem cells market is divided into three categories: stem cell therapeutics, cord blood banking and drug development tools based on the application. Stem cell therapeutics account for a major portion of the market which has been boosted by recent technological breakthroughs that expanded the scope of therapeutic uses. North America is the largest market for stem cells for 2009 with a share of slightly over one-third of global market while Europe is projected to be the second largest and second fastest growing market.
US is the major stem cell market in the world and has recently been boosted by the decision on lifting the 8 years old ban on federal funding for embryonic stem cell research on March 2009. Despite of the technological and ethical challenges surrounding the utilization of embryonic stem cells, recent developments to grow human embryonic stem cells in culture and an increased understanding of the pathways of cell differentiation have expanded the horizon of likely therapeutic uses. In addition, rising patient population, demand for umbilical cord cell banking and transplantation have increased the demand for stem cells development.
The current report covers the overview, market size and segmentation of the worldwide stem cell product market. The US market for stem cells is also discussed in detail. The various drivers and the challenges faced by the market are also discussed in detail. The competitive aspect of the market is also highlighted and the key players are profiled with their strategies for this market.
US is the major stem cell market in the world and has recently been boosted by the decision on lifting the 8 years old ban on federal funding for embryonic stem cell research on March 2009. Despite of the technological and ethical challenges surrounding the utilization of embryonic stem cells, recent developments to grow human embryonic stem cells in culture and an increased understanding of the pathways of cell differentiation have expanded the horizon of likely therapeutic uses. In addition, rising patient population, demand for umbilical cord cell banking and transplantation have increased the demand for stem cells development.
The current report covers the overview, market size and segmentation of the worldwide stem cell product market. The US market for stem cells is also discussed in detail. The various drivers and the challenges faced by the market are also discussed in detail. The competitive aspect of the market is also highlighted and the key players are profiled with their strategies for this market.
1. STEM CELLS: AN OVERVIEW
1.1 Sources of Stem Cells
1.1.1 Embryonic stem cells
1.1.2 Adult Stem Cells
Stem Cell Discovery Timeline
Comparison of Different Sources of Stem Cells
1.2 Applications of Stem Cells
1.2.1 Treatment of Major Diseases
1.2.2 Testing and Development of Drugs
1.2.3 Gene Therapy
1.2.4 Regenerative Medicine
2. GLOBAL STEM CELL MARKET
2.1 Market Size and Growth
Global Stem Cell Product Market (2006-2015E)
Category wise segmentation of Stem Cell Market (2015E)
Global Stem Cell Market by Therapeutic Areas (2010)
Global Stem Cell Technologies (2010): Breakdown
2.2 Geographical Segmentation
3. THE US STEM CELL MARKET
3.1 Market Overview
US stem Cell Market by Therapeutic Area (2018E)
Funding for Stem Cell Research in the US (2005-2008)
Segmentation of Types of Stem Cell Research on the basis of Funding (2008)
3.2 Market Size
The US Stem Cell Market (2006-2010E)
4. STEM CELL MARKET:KEY DRIVERS
4.1 Potential Therapeutic Applications
4.2 Increasing Government Funding
4.3 New Regulations- Lifting Ban on Embryonic Stem Cell Research
4.4 Demand for Umbilical Cord Cell Banking
4.5 Rising Patient Population
5. MARKET OPPORTUNITIES
5.1 India and China- A Growing Potential
5.2 Transplantation
6. INDUSTRY CHALLENGES
6.1 Ethical Issues
6.2 Strict Government Regulations
7. STEM CELL:MARKET OUTLOOK
8. STEM CELL: COMPANY ANALYSIS
8.1 Osiris Therapeutics Inc.
8.1.1 Business Description
8.1.2 Business Strategies
8.2.3 Significant Developments
8.2.4 Intellectual Property Portfolio
8.2 Cytori Therapeutics, Inc
8.2.1 Business Description
8.2.2 Business Strategies
8.2.3 Significant Developments
8.2.4 Product Patents
8.3 ThermoGenesis Corp.
8.3.1 Business Description
8.3.2 Business Strategies
8.3.3 Significant Developments
8.3.4 Product Patents
8.4 Neostem Inc.
8.4.1 Business Description
8.4.2 Business Strategies
8.4.3 Significant Developments
8.4.4 Product Patents
1.1 Sources of Stem Cells
1.1.1 Embryonic stem cells
1.1.2 Adult Stem Cells
Stem Cell Discovery Timeline
Comparison of Different Sources of Stem Cells
1.2 Applications of Stem Cells
1.2.1 Treatment of Major Diseases
1.2.2 Testing and Development of Drugs
1.2.3 Gene Therapy
1.2.4 Regenerative Medicine
2. GLOBAL STEM CELL MARKET
2.1 Market Size and Growth
Global Stem Cell Product Market (2006-2015E)
Category wise segmentation of Stem Cell Market (2015E)
Global Stem Cell Market by Therapeutic Areas (2010)
Global Stem Cell Technologies (2010): Breakdown
2.2 Geographical Segmentation
3. THE US STEM CELL MARKET
3.1 Market Overview
US stem Cell Market by Therapeutic Area (2018E)
Funding for Stem Cell Research in the US (2005-2008)
Segmentation of Types of Stem Cell Research on the basis of Funding (2008)
3.2 Market Size
The US Stem Cell Market (2006-2010E)
4. STEM CELL MARKET:KEY DRIVERS
4.1 Potential Therapeutic Applications
4.2 Increasing Government Funding
4.3 New Regulations- Lifting Ban on Embryonic Stem Cell Research
4.4 Demand for Umbilical Cord Cell Banking
4.5 Rising Patient Population
5. MARKET OPPORTUNITIES
5.1 India and China- A Growing Potential
5.2 Transplantation
6. INDUSTRY CHALLENGES
6.1 Ethical Issues
6.2 Strict Government Regulations
7. STEM CELL:MARKET OUTLOOK
8. STEM CELL: COMPANY ANALYSIS
8.1 Osiris Therapeutics Inc.
8.1.1 Business Description
8.1.2 Business Strategies
8.2.3 Significant Developments
8.2.4 Intellectual Property Portfolio
8.2 Cytori Therapeutics, Inc
8.2.1 Business Description
8.2.2 Business Strategies
8.2.3 Significant Developments
8.2.4 Product Patents
8.3 ThermoGenesis Corp.
8.3.1 Business Description
8.3.2 Business Strategies
8.3.3 Significant Developments
8.3.4 Product Patents
8.4 Neostem Inc.
8.4.1 Business Description
8.4.2 Business Strategies
8.4.3 Significant Developments
8.4.4 Product Patents
LIST OF GRAPHS
Stem Cell Discovery Timeline
Global Stem Cell Product Market (2006-2015E)
Category wise segmentation of Global Stem Cell Market (2015E)
Global Stem Cell Market by Therapeutic Areas (2010)
Breakdown by Global Stem Cell Technologies (2010)
Percentage Breakdown of Global Stem Cell Market by Geographic Region (2009)
US stem Cell Market by Therapeutic Area (2018E)
Segmentation of Types of Stem Cell Research on the basis of Funding (2008)
The US Stem Cell Market (2006-2010E)
Funding for Stem Cell Research (2005-2008)
Worldwide Total Cord Blood Banks (2005-2010)
US projected rise in chronic disease (2003-2023)
Worldwide Deaths due to Chronic Diseases (2008)
Stem Cell Research in India by Therapeutic Areas (2009)
Market Forecast for the US Stem Cell Market (2009E-2016E)
Annual Revenue of Osiris Therapeutics Inc (2005-2009)
Annual Revenues of Cytori Therapeutics Inc. (2005-2009)
Annual Revenue of ThermoGenesis Corp. (2006-2010)
Annual Revenues of NeoStem Inc. (2007-2009)
Stem Cell Discovery Timeline
Global Stem Cell Product Market (2006-2015E)
Category wise segmentation of Global Stem Cell Market (2015E)
Global Stem Cell Market by Therapeutic Areas (2010)
Breakdown by Global Stem Cell Technologies (2010)
Percentage Breakdown of Global Stem Cell Market by Geographic Region (2009)
US stem Cell Market by Therapeutic Area (2018E)
Segmentation of Types of Stem Cell Research on the basis of Funding (2008)
The US Stem Cell Market (2006-2010E)
Funding for Stem Cell Research (2005-2008)
Worldwide Total Cord Blood Banks (2005-2010)
US projected rise in chronic disease (2003-2023)
Worldwide Deaths due to Chronic Diseases (2008)
Stem Cell Research in India by Therapeutic Areas (2009)
Market Forecast for the US Stem Cell Market (2009E-2016E)
Annual Revenue of Osiris Therapeutics Inc (2005-2009)
Annual Revenues of Cytori Therapeutics Inc. (2005-2009)
Annual Revenue of ThermoGenesis Corp. (2006-2010)
Annual Revenues of NeoStem Inc. (2007-2009)
LIST OF TABLES
Comparison of Different Sources of Stem Cells
Units of Cord Blood Stem Cells Collected in Selective Countries (2008)
Funding for Stem Cell Research in the US (2005-2008)
Procedure Volume for Proprietary Stem Cell Therapies by Disease in Thousands (2012-2020)
Osiris Inc. Different Biologic Drug Candidates and its Status (2009)
Cytori Inc’s Current Products Along With Issued Patents
Cytori’s Future Generation Products in Development
Comparison of Different Sources of Stem Cells
Units of Cord Blood Stem Cells Collected in Selective Countries (2008)
Funding for Stem Cell Research in the US (2005-2008)
Procedure Volume for Proprietary Stem Cell Therapies by Disease in Thousands (2012-2020)
Osiris Inc. Different Biologic Drug Candidates and its Status (2009)
Cytori Inc’s Current Products Along With Issued Patents
Cytori’s Future Generation Products in Development
